Rare diseases
Investigational molecules
Locations
Back to Italy906 clinical trials in Bologna, Italy across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)A study of ACR-368 and gemcitabine for patients with endometrial cancer
ItalyA study of ABBV-706 and atezolizumab for patients with previously untreated extensive stage small cell lung cancer
ItalyA study to compare glofitamab against a drug combination for patients with relapsed or refractory mantle cell lymphoma
ItalyA study to evaluate the effectiveness of R2R01 in preventing acute kidney injury in patients at high risk following heart surgery.
ItalyA study to evaluate the safety of ADX-038 in patients with complement-mediated kidney disease
ItalyA study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease
ItalyA study of palazestrant and ribociclib compared to letrozole and ribociclib for patients with advanced ER+ HER2- breast cancer
ItalyA study of DS-3790A, rituximab, and epcoritamab in patients with blood cancers
ItalyA study to evaluate the effectiveness of pirtobrutinib in elderly and frail patients with mantle cell lymphoma who have not yet received treatment.
ItalyStudy of Revumenib, Cytarabine, and Fludarabine in Children with Relapsed or Refractory Acute Myeloid Leukemia
ItalyStudy of ziftomenib with drug combinations for adults with newly diagnosed acute myeloid leukemia with NPM1 or KMT2A genetic changes
ItalyA study to evaluate the safety and effectiveness of tafasitamab in adults with autoimmune thrombocytopenia or autoimmune hemolytic anemia
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Immune Thrombocytopenia and various forms of blood cancers including Acute Myeloid Leukemia and Multiple Myeloma. These trials aim to evaluate novel therapeutic approaches and combination treatments.
Studies include evaluation of new compounds and their safety profiles in treating various blood-related conditions.
Comprehensive studies on inflammatory bowel conditions, focusing on Crohn's Disease and Ulcerative Colitis. Research aims to develop more effective treatments for patients with moderate to severe disease activity.
Trials evaluate both induction therapy and long-term treatment options for gastrointestinal conditions.
Investigation of treatments for sleep disorders including Narcolepsy and Idiopathic Hypersomnia, along with research into Chronic Inflammatory Demyelinating Polyneuropathy.
Focus on developing safer and more effective therapies for various neurological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
